Fidelity Disruptive Medicine ETF (FMED)

Profile

The Fidelity Disruptive Medicine ETF is an exchange-traded fund designed to provide exposure to companies that are on the cutting edge of medical innovation. This ETF focuses on businesses that are involved in the development and application of revolutionary medical technologies, which might include areas such as gene editing, biotechnology, pharmaceutical advancements, and medical devices. By concentrating on these sectors, the ETF aims to capture growth opportunities from companies that are transforming healthcare with new treatments and technologies. In doing so, it supports investors seeking to capitalize on significant developments in the healthcare space. The ETF's role in the market is to serve as a dynamic investment vehicle that reflects the rapid pace of change in the medical field, potentially offering portfolio diversification through exposure to emerging market trends in healthcare.